FDA Center for Drug Evaluation and Research
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:abbreviation |
gptkb:CDER
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:director |
gptkb:Patrizia_Cavazzoni
|
| gptkbp:established |
1987
|
| gptkbp:headquartersLocation |
gptkb:Silver_Spring,_Maryland
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDA Center for Drug Evaluation and Research
|
| gptkbp:jurisdiction |
gptkb:United_States
|
| gptkbp:mission |
to ensure that safe and effective drugs are available to improve the health of people in the United States
|
| gptkbp:parentOrganization |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:partOf |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:responsibleFor |
regulation of over-the-counter drugs
regulation of prescription drugs approval of new drugs monitoring drug safety |
| gptkbp:website |
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder
|
| gptkbp:bfsParent |
gptkb:Abbreviated_New_Drug_Applications
gptkb:Investigational_New_Drug_applications gptkb:REMS |
| gptkbp:bfsLayer |
6
|